作者：
Gazzah, Anas [1]
;
Boni, Valentina [2]
;
Soria, Jean-Charles [3]
;
Calles, Antonio [4]
;
Even, Caroline [5]
;
Doger, Bernard [6]
;
Mahjoubi, Linda [7]
;
Bahleda, Rastislav ;
Ould-Kaci, Mahmoud ;
Esler, Anne ;
Nazabadioko, Serge ;
Calvo, Emiliano
作者单位：
Boehringer Ingelheim Pharmaceut Inc, Clin Dev & Med Affairs, 900 Ridgebury Rd, Ridgefield, CT 06877
[1]
Gustave Roussy Canc Campus, Drug Dev Dept, 114 Rue Edouard Vaillant, F-94805 Villejuif, France
[2]
Syneos Hlth, Stat, 3201 Beechleaf Court, Raleigh, NC 27604 USA
[3]
Boehringer Ingelheim GmbH & Co KG, Dept Med, 12 Rue Andre Huet, F-51721 Reims, France
[4]
START Madrid Fdn Jimenez Diaz, Med Oncol Phase Unit 1, Ave Reyes Catolicos 2, Madrid 28040, Spain
[5]
START Madrid Ctr Integral Oncol Clara Campal, Div Med Oncol, Calle Ona 10, Madrid 28050, Spain
[6]
Gustave Roussy Canc Campus, Dept Head & Neck Canc, 114 Rue Edouard Vaillant, F-94805 Villejuif
[7]
发布时间
2019-05-22
换一批
换一批
